Fibrinolytic biomarkers can aid in risk assessment for COVID-19 patients. (IMAGE)

Juntendo University Research Promotion Center

Fibrinolytic biomarkers can aid in risk assessment for COVID-19 patients.

Caption

Significant decreases in circulating uPA and uPA/PAI-1 complex levels may be a novel biomarker of COVID-19 severity.

Credit

Dr. Koichi Hattori from Juntendo University, Japan

Usage Restrictions

You can share and adapt the infographic, but attribution is required, with a link to the news source.

License

Original content

Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.